InvestorsHub Logo
icon url

theorysuit

04/21/24 1:46 PM

#686319 RE: exwannabe #686318

How better to keep self deal alive to revimmune when advent and cognate weren't enough. Have your paid pumps generate some hype around this early stage data and company. We can pivot to combination therapy and kick the goal posts 200 more yards down the road. Let's keep continuing this conflict of interest scam to more unsuspecting retail. Keep adding fleas to this POS. The story keeps getting better and better.....unbelievable. And you all wonder why you are on the POS OTC.


All this is noise....the only thing that can save this is both approval and buyout. Approval alone is not even enough with no path to profitability.
icon url

flipper44

04/21/24 1:55 PM

#686320 RE: exwannabe #686318

I think there is a tendency to project how they will deal with revimmune’s patent interest in the dc + ci patent.

IMO, LP would have had that worked out in some agreement of understanding with the three or four main parties back when she had the patent app filed in 2015.

I simply can’t worry about these things. I assume it’s just a very good thing Europe, in addition to a few countries outside Europe, already granted the combination patent.
icon url

dstock07734

04/21/24 5:05 PM

#686344 RE: exwannabe #686318

Ex,

Does it make sense to you now that I have included Sanofi in my BP job postings?
icon url

dstock07734

04/21/24 6:11 PM

#686355 RE: exwannabe #686318

Hype? How could you know it is hype? It could be a reality about to unfold.

Now look at some of job postings from Sanofi. Is this hype too? BTW, does whosleftholdindabag now pay you more since it seems a risky job now?

Director Digital & Artificial Intelligence
https://en.jobs.sanofi.com/job/cambridge/director-digital-and-artificial-intelligence/20873/63131385440

The Global Device & Packaging Unit is a global business Unit in Sanofi M&S which develops and maintains Sanofi`s parenteral injection systems like Insulin Pens, Autoinjectors, Large Volume Devices, infusion systems and Pre-Filled Syringes. The Unit is a project-centric organization which is executing development and LCM projects of drug delivery devices for mAbs, vaccines, peptides, genomics etc. and supports device product maintenance post launch.



Process Engineer/ Analytical Dev Sp II
https://en.jobs.sanofi.com/job/geel/process-engineer-analytical-dev-sp-ii/20873/63772917440

Develop, execute and/or transfer liquid-chromatography coupled to mass spectrometry (LC-MS) methods.



Global Research Postdoctoral Fellow - AI for Patient Stratification and Precision Medicine
https://en.jobs.sanofi.com/job/cambridge/global-research-postdoctoral-fellow-ai-for-patient-stratification-and-precision-medicine/20873/55227920384

Utilizing large datasets including genetic, transcriptomic, single cell, proteomic, imaging and electronic medical record data to train foundational deep learning models on disease specific context.



POSTDOC - Scientist
https://en.jobs.sanofi.com/job/vitry-sur-seine/postdoc-scientist/20873/61236069872

Postdoctoral fellowship - Immuno-Oncology - deciphering myeloid cell heterogeneity in solid tumors (All Gender)



Principal Statistician - Research (Non-Clinical)
https://en.jobs.sanofi.com/job/cambridge/principal-statistician-research-non-clinical/20873/63702673184

The Non-Clinical Efficacy and Safety (NCES) team, within the Global Biostatistics and Programming Department of Sanofi R&D, contributes to reliability, scientific quality and optimization of Projects/Programs support from "target identification" to "compounds in development” by providing appropriate non clinical statistical support for efficacy and safety internal or external studies for all R&D entities.